T. Rowe Price Associates’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.3M | Buy |
|
|||||
|
2025
Q2 | $978K | Sell |
|
|||||
|
2025
Q1 | $12.7M | Sell |
|
|||||
|
2024
Q4 | $22.7M | Sell |
|
|||||
|
2024
Q3 | $34.5M | Sell |
|
|||||
|
2024
Q2 | $35.9M | Sell |
|
|||||
|
2024
Q1 | $60.2M | Buy |
|
|||||
|
2023
Q4 | $67.5M | Buy |
|
|||||
|
2023
Q3 | $28M | Buy |
|
|||||
|
2023
Q2 | $371K | Sell |
|
|||||
|
2023
Q1 | $6.88M | Buy |
|
|||||
|
2022
Q4 | $4.9M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $197K | Buy |
|
|||||
|
2021
Q2 | $186K | Buy |
|
|||||
|
2021
Q1 | $277K | Sell |
|
|||||
|
2020
Q4 | $13.4M | Buy |
|
|||||
|
2020
Q3 | $7.23M | Buy |
|